CJC1295 5mg DAC Laboratory Research Compound

CJC-1295 DACCJC-1295 DAC is a modified GHRH analogue incorporating a Drug Affinity Complex (DAC), designed to extend peptide half-life. It is frequently studied for sustained peptide-receptor interaction and long-term signalling pathways in vitro. Its stability profile is of particular interest in peptide research.Disclaimer: For laboratory research use only. Not for human or animal use.